Recent evidence shows that human neutrophil elastase inhibitors can be synthesized locally at mucosal sites. In addition to efficiently targeting bacterial and host enzymes, they can be released in the interstitium and in the lumen of mucosa, where they have been shown to have antimicrobial activities, and to activate innate immune responses. This review will address more particularly the pleiotropic functions of low-molecular-mass neutrophil elastase inhibitors [SLPI (secretory leucocyte proteinase inhibitor) and elafin] and, more specifically, their role in the development of the adaptive immune response.
Conference Article| March 20 2006
Human neutrophil elastase inhibitors in innate and adaptive immunity
J.-M. Sallenave 1
1MRC Centre for Inflammation Research, University of Edinburgh, The Queens Medical Research Institute, 47 Little France Crescent, Edinburgh EH16 4TJ, Scotland, U.K.
1To whom correspondence should be addressed (email J.Sallenave@ed.ac.uk).
Search for other works by this author on:
- Views Icon Views
- Share Icon Share
- Cite Icon Cite
P.M. Fitch, A. Roghanian, S.E.M. Howie, J.-M. Sallenave; Human neutrophil elastase inhibitors in innate and adaptive immunity. Biochem Soc Trans 1 April 2006; 34 (2): 279–282. doi: https://doi.org/10.1042/BST0340279
Download citation file: